Bionano Genomics (BNGO) Work In Process (2021 - 2026)

Bionano Genomics has disclosed Work In Process across 6 years of filings, most recently posting $136000.0 for Q1 2026.

• Work In Process for Q1 2026 came in at $136000.0, down 91.3% year-over-year; the trailing twelve-month figure through Mar 2026 was $136000.0 (down 91.3% YoY), and the FY2025 annual result was $663000.0, down 71.78% from the prior year.
• Work In Process came in at $136000.0 for Q1 2026 at Bionano Genomics, down from $663000.0 in the prior quarter.
• In the past five years, Work In Process ranged from a high of $10.6 million in Q2 2023 to a low of $136000.0 in Q1 2026.
• The 5-year median for Work In Process is $4.6 million (2024), against an average of $5.1 million.
• Across the five-year window, Work In Process surged 325.0% in 2022 and tumbled 91.3% in 2026, its largest moves.
• Bionano Genomics' Work In Process stood at $7.1 million in 2022, then jumped by 38.77% to $9.8 million in 2023, then sank by 76.01% to $2.3 million in 2024, then sank by 71.78% to $663000.0 in 2025, then sank by 79.49% to $136000.0 in 2026.
• The last three Work In Process figures came in at $136000.0 (Q1 2026), $663000.0 (Q4 2025), and $388000.0 (Q3 2025), per Business Quant data.